NCT04836572View on ClinicalTrials.gov

An Open-label, Non Significant Risk, Adhesive Wear Validation Study for the On Body Drug Delivery Device Component of the SQIN-01 Furosemide Infusor (Infusor Device)

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 20, 2021

Primary Completion Date

March 4, 2021

Study Completion Date

March 4, 2021

Conditions
Healthy Volunteer Study
Interventions
OTHER

3M 1529 Adhesive Tape

5-12 hour adhesive wear

Trial Locations (1)

01752

Community Clinical Research Network, Marlborough

Sponsors
All Listed Sponsors
collaborator

Community Clinical Research Network

UNKNOWN

lead

SQ Innovation, Inc.

INDUSTRY

NCT04836572 - An Open-label, Non Significant Risk, Adhesive Wear Validation Study for the On Body Drug Delivery Device Component of the SQIN-01 Furosemide Infusor (Infusor Device) | Biotech Hunter | Biotech Hunter